Clinical trial
Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE)…
NCT00128934 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00128934 |
|---|---|
| Title | Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menstruation Disturbances, Premenstrual Syndrome |
| Intervention type | Drug |
| Interventions | levonorgestrel/ethinyl estradiol |
| Enrollment | 744 |
| Start date | Aug 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Aug 10, 2005 |
| Last update posted | Dec 27, 2007 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: